Yoshida Y - Search Results

1

2023 update and perspectives.

Mogi M, Tanaka A, Node K, Tomitani N, Hoshide S, Narita K, Nozato Y, Katsurada K, Maruhashi T, Higashi Y, Matsumoto C, Bokuda K, Yoshida Y, Shibata H, Toba A, Masuda T, Nagata D, Nagai M, Shinohara K, Kitada K, Kuwabara M, Kodama T, Kario K. Mogi M, et al. Among authors: yoshida y. Hypertens Res. 2024 Jan;47(1):6-32. doi: 10.1038/s41440-023-01398-5. Epub 2023 Sep 15. Hypertens Res. 2024. PMID: 37710033 Review.

2

[Secondary hypertension].

Yoshida Y, Shibata H. Yoshida Y, et al. Nihon Rinsho. 2015 Nov;73(11):1925-31. Nihon Rinsho. 2015. PMID: 26619670 Japanese.

3

Fulminant type 1 diabetes mellitus with anti-programmed cell death-1 therapy.

Okamoto M, Okamoto M, Gotoh K, Masaki T, Ozeki Y, Ando H, Anai M, Sato A, Yoshida Y, Ueda S, Kakuma T, Shibata H. Okamoto M, et al. Among authors: yoshida y. J Diabetes Investig. 2016 Nov;7(6):915-918. doi: 10.1111/jdi.12531. Epub 2016 May 31. J Diabetes Investig. 2016. PMID: 27181090 Free PMC article.

4

Effects of Sleeve Gastrectomy on Blood Pressure and the Renal Renin-Angiotensin System in Rats with Diet-Induced Obesity.

Yoshida Y, Gotoh K, Masaki T, Ozeki Y, Tokoro M, Kudo A, Ozaki T, Okamoto M, Chiba S, Watanabe K, Ohta M, Inomata M, Shibata H. Yoshida Y, et al. Obesity (Silver Spring). 2019 May;27(5):785-792. doi: 10.1002/oby.22443. Epub 2019 Mar 29. Obesity (Silver Spring). 2019. PMID: 30925198

5

Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism.

Satoh M, Maruhashi T, Yoshida Y, Shibata H. Satoh M, et al. Among authors: yoshida y. Hypertens Res. 2019 Jun;42(6):817-824. doi: 10.1038/s41440-019-0244-4. Epub 2019 Apr 5. Hypertens Res. 2019. PMID: 30948836

6

Relationships between computed tomography-assessed density, abdominal fat volume, and glucose metabolism after sleeve gastrectomy in Japanese patients with obesity.

Ozeki Y, Masaki T, Yoshida Y, Okamoto M, Anai M, Gotoh K, Endo Y, Ohta M, Inomata M, Shibata H. Ozeki Y, et al. Among authors: yoshida y. Endocr J. 2019 Jul 28;66(7):605-613. doi: 10.1507/endocrj.EJ18-0543. Epub 2019 Apr 23. Endocr J. 2019. PMID: 31019152 Free article.

7

Oral Salt Loading Test is Associated With 24-Hour Blood Pressure and Organ Damage in Primary Aldosteronism Patients.

Yoshida Y, Yoshimura S, Kinoshita M, Ozeki Y, Okamoto M, Gotoh K, Masaki T, Shibata H. Yoshida Y, et al. J Endocr Soc. 2020 Aug 24;4(10):bvaa116. doi: 10.1210/jendso/bvaa116. eCollection 2020 Oct 1. J Endocr Soc. 2020. PMID: 32968702 Free PMC article.

8

Quality of Life of Primary Aldosteronism Patients by Mineralocorticoid Receptor Antagonists.

Yoshida Y, Yoshida R, Shibuta K, Ozeki Y, Okamoto M, Gotoh K, Masaki T, Shibata H. Yoshida Y, et al. Among authors: yoshida r. J Endocr Soc. 2021 Feb 16;5(4):bvab020. doi: 10.1210/jendso/bvab020. eCollection 2021 Apr 1. J Endocr Soc. 2021. PMID: 33817540 Free PMC article.

9

Dopamine-Secreting Pheochromocytoma and Paraganglioma.

Miyamoto S, Yoshida Y, Ozeki Y, Okamoto M, Gotoh K, Masaki T, Nishida H, Shibuya T, Shin T, Daa T, Mimata H, Kimura N, Shibata H. Miyamoto S, et al. Among authors: yoshida y. J Endocr Soc. 2021 Oct 29;5(12):bvab163. doi: 10.1210/jendso/bvab163. eCollection 2021 Dec 1. J Endocr Soc. 2021. PMID: 34870059 Free PMC article. Review.

10

Optimal blood pressure target to prevent severe hypertension in pregnancy: A systematic review and meta-analysis.

Abe M, Arima H, Yoshida Y, Fukami A, Sakima A, Metoki H, Tada K, Mito A, Morimoto S, Shibata H, Mukoyama M. Abe M, et al. Among authors: yoshida y. Hypertens Res. 2022 May;45(5):887-899. doi: 10.1038/s41440-022-00853-z. Epub 2022 Feb 8. Hypertens Res. 2022. PMID: 35136186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,839 results

Search Page